The Role of Medication Use in Reducing the Hospital Length of Stay in Circulatory System Diseases

zObjective: Optimizing medication use is critical to minimize the hospital length of stay in circulatory system diseases.In this respect, the aim of this study was to examine the role of medication use in reducing the hospital average length of stay in circulatory system diseases. Methods:In line with the aim of the study, the independent variables were the uses (in daily doses) of cardiac glycoside, anti-arrhythmic, anti-hypertensive, diuretic, and beta-blocking medications, while the dependent variable was the hospital average length of stay (in days) due to circulatory system diseases.The population of the study consisted of 38 Organisation for Economic Co-operation and Development (OECD) countries.Data from the years 2018-2021 were obtained from the OECD database.A panel least squares regression analysis was performed. Results:According to the analysis results, the regression model was found to be statistically significant (p<0.01).Additionally, anti-hypertensive (t=-2.740,p=0.006), diuretic (t=-2.073,p=0.040), and beta-blocker (t=-2.019,p=0.044) medication consumption made significant contributions to the model.As the use of anti-hypertensive, diuretic, and beta-blocking medications increased, the average hospital length of stay decreased. Conclusion:The use of anti-hypertensive diuretic, and beta-blocking medications plays an important role in reducing the average hospital length of stay of patients with circulatory system diseases.This emphasizes the importance of these medicines in the effective management of circulatory conditions, which may lead to faster patient recovery and more efficient use of health resources.